|
James R. Langevin
|
house |
Alexion Pharmaceuticals, Inc. (ALXN) |
ALXN |
STOCK |
Purchase
|
Jan. 6, 2017 |
$$15,001 - $50,000 |
Jan. 13, 2017 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 22, 2016 |
$$15,001-50,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 19, 2016 |
$$1,000,001-5,000,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 19, 2016 |
$$50,001-100,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Nov. 17, 2016 |
$$1,000-$15,000 |
Dec. 21, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 4, 2016 |
$$15,001-$50,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 4, 2016 |
$$1,000-$15,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Oct. 2, 2016 |
$$1,000-15,000 |
Nov. 17, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 30, 2016 |
$$15,001-$50,000 |
Oct. 14, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 29, 2016 |
$$15,001-$50,000 |
Oct. 14, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Sept. 7, 2016 |
$$1,000-$15,000 |
Oct. 14, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
July 26, 2016 |
$nan |
Aug. 16, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
July 14, 2016 |
$nan |
Aug. 16, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
March 24, 2016 |
$$1,000-$15,000 |
April 20, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Dec. 17, 2015 |
$$1,000-15,000 |
Feb. 3, 2016 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
PURCHASE
|
Aug. 20, 2015 |
$$15,001-$50,000 |
Sept. 25, 2015 |
|
James B. Renacci
|
house |
ALEXION PHARMACEUTICALS INCORPORATED (ALXN) |
ALXN |
STOCK |
PURCHASE
|
Aug. 3, 2015 |
$$50,001 - $100,000 |
Aug. 25, 2015 |
|
James B. Renacci
|
house |
ALEXION PHARMACEUTICALS INCORPORATED (ALXN) |
ALXN |
STOCK |
PURCHASE
|
July 31, 2015 |
$$15,001 - $50,000 |
Aug. 11, 2015 |
|
James B. Renacci
|
house |
ALEXION PHARMACEUTICALS INCORPORATED (ALXN) |
ALXN |
STOCK |
PURCHASE
|
July 30, 2015 |
$$1,000 - $15,000 |
Aug. 11, 2015 |
|
K. Michael Conaway
|
house |
Alexion Pharmaceuticals, Inc. (ALXN) |
ALXN |
STOCK |
Purchase
|
Feb. 9, 2015 |
$$1,001 - $15,000 |
March 3, 2015 |
|
Thomas MacArthur
|
house |
Alexion Pharmaceuticals, Inc. (ALXN) |
ALXN |
STOCK |
Sale
|
Jan. 27, 2015 |
$$1,001 - $15,000 |
March 5, 2015 |
|
Thomas MacArthur
|
house |
Alexion Pharmaceuticals, Inc. (ALXN) |
ALXN |
STOCK |
Purchase
|
Jan. 21, 2015 |
$$1,001 - $15,000 |
March 5, 2015 |
|
Michael T. McCaul
|
house |
ALEXION PHARMACEUTICALS INC |
ALXN |
STOCK |
Purchase
|
Dec. 20, 2014 |
$$1,000,001-$5,000,000 |
Jan. 21, 2015 |
|
James R. Langevin
|
house |
alexion Pharmaceuticals, Inc. (aLXN) |
ALXN |
STOCK |
Sale
|
Dec. 8, 2014 |
$$1,001 - $15,000 |
Dec. 12, 2014 |
|
James B. Renacci
|
house |
ALEXION PHARMACEUTICALS INCORPORATED (ALXN) |
ALXN |
STOCK |
SALE
|
July 29, 2014 |
$$1,000 - $15,000 |
Aug. 6, 2014 |